申请人:Eli Lilly and Company
公开号:US04379929A1
公开(公告)日:1983-04-12
Amide and ester derivatives of substituted-4(1H)-oxocinnoline-3-carboxylic acids have antibacterial activity and are useful for inhibiting the growth of disease causing bacteria.
取代的4(1H)-氧基喹啉-3-羧酸的酰胺和酯衍生物具有抗菌活性,并可用于抑制致病细菌的生长。